Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groettrup

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Critical Reviews in Immunology|April 2, 2002
Structural plasticity of the proteasome and its function in antigen processingM Groettrup, M van den Broek, K Schwarz, et al.
The Journal of Biological Chemistry|December 10, 1999
How an inhibitor of the HIV-I protease modulates proteasome activityG Schmidtke, H G Holzhütter, M Bogyo, et al.
Cancer Research|October 18, 2000
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancerJ Dannull, P A Diener, L Prikler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitopeK Schwarz, M van Den Broek, S Kostka, et al.
Nature Medicine|December 2, 2000
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell toleranceA Limmer, J Ohl, C Kurts, et al.
Oncogene|June 25, 2008
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colonS Lukasiak, C Schiller, P Oehlschlaeger, et al.
Nature|May 9, 1996
A role for the proteasome regulator PA28alpha in antigen presentationM Groettrup, A Soza, M Eggers, et al.
Cell|July 26, 1996
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligandsT P Dick, T Ruppert, M Groettrup, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic dosesK Schwarz, R de Giuli, G Schmidtke, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responsesP André, M Groettrup, P Klenerman, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Critical Reviews in Immunology|April 2, 2002
Structural plasticity of the proteasome and its function in antigen processingM Groettrup, M van den Broek, K Schwarz, et al.
The Journal of Biological Chemistry|December 10, 1999
How an inhibitor of the HIV-I protease modulates proteasome activityG Schmidtke, H G Holzhütter, M Bogyo, et al.
Cancer Research|October 18, 2000
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancerJ Dannull, P A Diener, L Prikler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitopeK Schwarz, M van Den Broek, S Kostka, et al.
Nature Medicine|December 2, 2000
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell toleranceA Limmer, J Ohl, C Kurts, et al.
Oncogene|June 25, 2008
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colonS Lukasiak, C Schiller, P Oehlschlaeger, et al.
Nature|May 9, 1996
A role for the proteasome regulator PA28alpha in antigen presentationM Groettrup, A Soza, M Eggers, et al.
Cell|July 26, 1996
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligandsT P Dick, T Ruppert, M Groettrup, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic dosesK Schwarz, R de Giuli, G Schmidtke, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responsesP André, M Groettrup, P Klenerman, et al.
Pageof 5